US 9,284,320 B2Granted

Ticagrelor adducts with divalent metal salts

AssigneeLek Pharmaceuticals D.D.

InventorBorut Zupancic

Life of this patent

Estimating the term…

Abstract

The present invention relates to amorphous adducts of ticagrelor with divalent metal salts useful in the treatment or prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease.

Claims9

Dependent claims

An adduct of a compound of formula I with a divalent metal salt

Dependencies are inferred from the claim text.

Facts

Application: 14/411,553Filed 3 Jul 2013
Priority: EP 121749324 Jul 2012
Published: US 2015/0191475 A19 Jul 2015
Granted: 15 Mar 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 487/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/519
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with heterocyclic rings
A61P 7/02
Drugs for disorders of the blood or the extracellular fluid: antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A61P 9/10
Drugs for disorders of the cardiovascular system: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary…

Family

US 2015/0191475 A1Pre-grant publication · published 9 Jul 2015
US 9,284,320 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results